FDA searches for new commissioner as Marty Makary departs, Trump administration outlines priorities

Marty Makary is leaving his role at the FDA, as reported in STAT’s D.C. Diagnosis newsletter.

The Trump administration has released a lengthy wish list for the next FDA commissioner, indicating the policy areas it wants the new leader to focus on.

The story was written by Washington correspondent John Wilkerson, who covers health policy for STAT and runs the D.C. Diagnosis newsletter.